Marker in liver transplant recipients

Conditions

LIVERFAILURE

Schmelzle M, Krenzien F, Dahlke P, Krombholz A, Nevermann N, Feldbrügge L, Winter A, Schöning W, Benzing C, Pratschke J, Neudecker J.

2022-02-0911 citations

10.21037/hbsn-21-294

Sensing Acute Cellular Rejection in Liver Transplant Patients Using Liver-Derived Extracellular Particles: A Prospective, Observational Study

Kaan Kamali, Moritz Schmelzle, Can Kamali, Philipp Brunnbauer, Katrin Splith et al. (18 authors)

Frontiers in Immunology2021-05-056 citations

10.3389/fimmu.2021.647900

Interventions

Group 1: Inclusion of patients following liver transplantation, analysis of blood according to the clinical routine (POD 0, POD 1, POD 3, POD 7, POD 14, POD 30, 6 Month, 12 Month) observational study,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: liver transplantation, liver resection, healthy volunteer, patient consent

Exclusion criteria

Exclusion criteria: Missing inclusion criteria, no patient consent.

Design outcomes

Primary

Measure	Time frame
The aim of the study is to determine markers indicating graft failure.	—

Secondary

Measure	Time frame
Graft function	—

Countries

Germany

Contacts

Public ContactFelix Krenzien

Department of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin

felix.krenzien@charite.de+49450552001

Outcome results

None listed